國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hereditary breast and ovarian cancer...

Aoki, Daisuke.

Hereditary breast and ovarian cancermolecular mechanism and clinical practice /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hereditary breast and ovarian canceredited by Seigo Nakamura, Daisuke Aoki, Yoshio Miki.
其他題名:	molecular mechanism and clinical practice /
其他作者:	Nakamura, Seigo.
出版者:	Singapore :Springer Singapore :2021.
面頁冊數:	viii, 324 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	BreastCancer
電子資源:	https://doi.org/10.1007/978-981-16-4521-1
ISBN:	9789811645211$q(electronic bk.)

Hereditary breast and ovarian cancermolecular mechanism and clinical practice /
Hereditary breast and ovarian cancermolecular mechanism and clinical practice /[electronic resource] :edited by Seigo Nakamura, Daisuke Aoki, Yoshio Miki. - Singapore :Springer Singapore :2021. - viii, 324 p. :ill., digital ;24 cm.

1 History, Advancements, and Future Strategies -- 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis -- 3 Genetic Testing -- 4 Variants of uncertain significances in hereditary breast and ovarian cancer -- 5 Genetic counseling in Hereditary Breast and Ovarian Cancer -- 6 Hereditary Breast Cancer -- 7 Hereditary Ovarian Cancer -- 8 Risk-Based Breast Cancer Screening -- 9 Chemoprevention for Breast Cancer -- 10 Chemoprevention for Ovarian Cancer -- 11 Risk-Reducing Mastectomy (RRM) -- 12 Risk-reducing salpingo-oophorectomy (RRSO) -- 13 Panel Testing -- 14 Germline Findings through Precision Oncology for Ovarian Cancer -- 15 Germline Findings from Genetic Testing for Breast Cancer -- 16 Hereditary Breast and Ovarian Cancer (HBOC) Database -- 17 Ethical Issues: Overview in Genomic analysis and Clinical Context -- 18 PARP Inhibitors-Mechanism of action -- 19 PARPi - Efficacy in Hereditary Breast Cancer -- 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer.

This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.

ISBN: 9789811645211$q(electronic bk.)

Standard No.: 10.1007/978-981-16-4521-1doiSubjects--Topical Terms:

357478
Breast
--Cancer

LC Class. No.: RC280.B8 / H47 2021

Dewey Class. No.: 616.99449042

Hereditary breast and ovarian cancermolecular mechanism and clinical practice /
LDR:03242nmm a2200325 a 4500 001 610786
003 DE-He213
005 20211020123159.0
006 m d
007 cr nn 008maaau
008 220330s2021 si s 0 eng d
020 $a 9789811645211$q(electronic bk.)
020 $a 9789811645204$q(paper)
024 7 $a 10.1007/978-981-16-4521-1 $2 doi
035 $a 978-981-16-4521-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8 $b H47 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99449042 $2 23
090 $a RC280.B8 $b H542 2021
245 0 0 $a Hereditary breast and ovarian cancer $h [electronic resource] : $b molecular mechanism and clinical practice / $c edited by Seigo Nakamura, Daisuke Aoki, Yoshio Miki.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a viii, 324 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1 History, Advancements, and Future Strategies -- 2 Molecular basis of BRCA1 and BRCA2 - Homologous recombination deficiency and tissue-specific carcinogenesis -- 3 Genetic Testing -- 4 Variants of uncertain significances in hereditary breast and ovarian cancer -- 5 Genetic counseling in Hereditary Breast and Ovarian Cancer -- 6 Hereditary Breast Cancer -- 7 Hereditary Ovarian Cancer -- 8 Risk-Based Breast Cancer Screening -- 9 Chemoprevention for Breast Cancer -- 10 Chemoprevention for Ovarian Cancer -- 11 Risk-Reducing Mastectomy (RRM) -- 12 Risk-reducing salpingo-oophorectomy (RRSO) -- 13 Panel Testing -- 14 Germline Findings through Precision Oncology for Ovarian Cancer -- 15 Germline Findings from Genetic Testing for Breast Cancer -- 16 Hereditary Breast and Ovarian Cancer (HBOC) Database -- 17 Ethical Issues: Overview in Genomic analysis and Clinical Context -- 18 PARP Inhibitors-Mechanism of action -- 19 PARPi - Efficacy in Hereditary Breast Cancer -- 20 Efficacy of Poly ADP-Ribose Polymerase Inhibitors for Hereditary Ovarian Cancer.
520 $a This highly informative and clearly written book presents the basic science and the latest data on hereditary breast and ovarian cancer (HBOC) to provide an up-to-date and holistic overview of the disease. It starts off by presenting the molecular mechanisms, genetic testing and counseling, and variants of unknown significance (VUS) to help readers understand the contemporary interpretation of the disease. Further chapters focus on the surveillance, diagnosis and treatment, including chemoprevention, risk reduction and drug development based on molecular mechanisms. It also includes a chapter on the latest findings from the HBOC database, ethical issues and the parp inhibitors, and discusses innovative thinking to manage and understand the disease. Hereditary Breast and Ovarian Cancer - Molecular Mechanism and Clinical Practice offers breast surgeons, medical oncologists, gynecological oncologists and genetic counselors a comprehensive overview of the disease. Providing insights into recent scientific findings and further avenues for investigation, it is also a thought-provoking and informative read for researchers and scholars.
650 0 $a Breast $x Cancer $x Genetic aspects. $3 357478
650 0 $a Breast $x Cancer $x Molecular aspects. $3 280479
650 0 $a Ovaries $x Cancer $x Genetic aspects. $3 908379
650 0 $a Ovaries $x Cancer $x Molecular aspects. $3 901266
650 1 4 $a Oncology. $3 195181
650 2 4 $a Surgical Oncology. $3 274092
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Human Genetics. $3 273658
650 2 4 $a Molecular Medicine. $3 273932
700 1 $a Nakamura, Seigo. $3 908982
700 1 $a Aoki, Daisuke. $3 908983
700 1 $a Miki, Yoshio. $3 908984
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-4521-1
950 $a Medicine (SpringerNature-11650)